Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Priveterra Acquisition Corp. PMGM |
Citadel Advisors LLC | 1,658 0.000% |
-1,379,464 (-99.88%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Citadel Advisors LLC | 4,057 0.000% |
-775,377 (-99.48%) |
Filing History |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Akili, Inc. AKLI |
Citadel Advisors LLC | 19,515 0.000% |
19,515 (New Position) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Independence Holdings Corp. ACQR |
Citadel Advisors LLC | 3,756,877 7.600% |
-400,258 (-9.63%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,747,391 7.400% |
12,322 (+0.71%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Bilander Acquisition Corp. TWCB |
Citadel Advisors LLC | 1,212,037 7.200% |
-73,522 (-5.72%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Apollo Strategic Growth Capital II APGB |
Citadel Advisors LLC | 4,078,643 5.900% |
-51,113 (-1.24%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Calithera Biosciences, Inc. CALA |
Citadel Advisors LLC | 249,336 5.100% |
249,336 (New Position) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,981,324 5.700% |
116,524 (+4.07%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Forbion European Acquisition Corp. FRBN |
Citadel Advisors LLC | 1,075,058 8.500% |
1,075,058 (New Position) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | G Squared Ascend II Inc. GSQB |
Citadel Advisors LLC | 1,220,439 8.500% |
85 (+0.01%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Citadel Advisors LLC | 2,155,134 5.900% |
26,926 (+1.27%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Khosla Ventures Acquisition Co. KVSA |
Citadel Advisors LLC | 2,705,290 7.600% |
370,682 (+15.88%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Khosla Ventures Acquisition Co. III KVSC |
Citadel Advisors LLC | 3,404,141 5.900% |
580,377 (+20.55%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO |
Citadel Advisors LLC | 2,241,549 6.500% |
-405,087 (-15.31%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | MSD Acquisition Corp. MSDA |
Citadel Advisors LLC | 3,428,296 6.000% |
-60,921 (-1.75%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Motive Capital Corp II MTVC |
Citadel Advisors LLC | 2,500,443 7.300% |
262 (+0.01%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Oncorus, Inc. ONCR |
Citadel Advisors LLC | 2,017,854 7.800% |
116,545 (+6.13%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Panacea Acquisition Corp. II PANA |
Citadel Advisors LLC | 1,501,251 8.400% |
273,545 (+22.28%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Jackson Acquisition Company RJAC |
Citadel Advisors LLC | 1,256,919 5.700% |
1,256,919 (New Position) |
Filing History |